Trending News
News
News
Plexera Bioscience Announces Agreement with Leading Therapeutic Antibody Company
Plexera has signed an Early Access Agreement with an undisclosed therapeutic antibody company as its first participant in its Early Access Program.
News
BioRelix and Dalton Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
Dalton Medicinal Chemistry will utilize their proprietary insights to design and synthesize several classes of compounds against selected RiboSwitch targets.
News
NextGen Sciences Appoints new CEO and Expands Service Offering
The Company appoints Dr Mike Pisano as CEO, and announces the expansion of its portfolio of services to include clinical protein biomarker monitoring.
News
Aureus Pharma Announces Renewal and Expansion of Licensing
Agreement with Bristol-Myers Squibb for Aureus’ AurSCOPE Knowledge databases.
News
Applied Biosystems and BioTrove to Collaborate on Integrated Platform for High Throughput Genotyping
Platform will simplify workflows and expand use of TaqMan® assays for a wide range of genotyping applications.
News
DIREVO and Pfizer Collaborate on Therapeutic Proteases
Direvo will apply its protein-engineering capabilities to create proteases with engineered specificity for different targets as potential treatments for various diseases.
News
Cambria Receives $5 Million Grants for Neurodegenerative Disease Drug Discovery and Preclinical Development Program
The grant funding will support the company’s drug discovery programs amyotrophic lateral sclerosis, muscular dystrophy and Parkinson’s disease.
News
Beactica Announces Drug Discovery Collaboration with Arrow Therapeutics
Beactica will direct its characterization technology at selected Arrow compounds against a confidential target.
News
Advion BioServices Announces Expansion
The Company is expanding its capacity with the recent acquisition of two Applied Biosystems/MDS Sciex API 5000 mass spectrometers and Waters Acquity UPLC capability.
News
PsychoGenics Announces Drug Discovery Agreement with Cephalon
Both companies will work together to identify new treatments for neuropsychiatric disorders.
Advertisement